Return to content in this issue

 

Long-term remission of Wells syndrome with omalizumab

Coattrenec Y1, Ibrahim LY2, Harr T1, Spoerl D1*, Jandus P1*

1Division of Immunology and Allergology, Department of Internal Medicine, University Hospital and Medical Faculty, Geneva, Switzerland
2Division of Clinical Pathology, University Hospital and Medical Faculty, Geneva, Switzerland
*DS and PJ contributed equally to this work.

J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0436

Key words: Wells syndrome, eosinophilic cellulitis, omalizumab, successful treatment